DE3853261D1 - Verwendung von Nitrophenylen oder Antinitrophenylen -Antikörpern zur Veränderung der Wechselwirkung zwischen empfindlichen Wirtszellen und einem Erreger. - Google Patents

Verwendung von Nitrophenylen oder Antinitrophenylen -Antikörpern zur Veränderung der Wechselwirkung zwischen empfindlichen Wirtszellen und einem Erreger.

Info

Publication number
DE3853261D1
DE3853261D1 DE3853261T DE3853261T DE3853261D1 DE 3853261 D1 DE3853261 D1 DE 3853261D1 DE 3853261 T DE3853261 T DE 3853261T DE 3853261 T DE3853261 T DE 3853261T DE 3853261 D1 DE3853261 D1 DE 3853261D1
Authority
DE
Germany
Prior art keywords
antibodies
interaction
antinitrophenylene
nitrophenylene
pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3853261T
Other languages
English (en)
Inventor
Eustrate-Stratis Avrameas
Panayota Matsiota-Bernard
Therese Ternynck
Marie-Francoise Saron
Jean-Claude Guillon
Luc Montagnier
Denise Guetard
Veronique Favier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE3853261D1 publication Critical patent/DE3853261D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3853261T 1987-10-30 1988-10-28 Verwendung von Nitrophenylen oder Antinitrophenylen -Antikörpern zur Veränderung der Wechselwirkung zwischen empfindlichen Wirtszellen und einem Erreger. Expired - Lifetime DE3853261D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8715126A FR2622444B1 (fr) 1987-10-30 1987-10-30 Application de dinitro-trinitrophenyle et de ses derives ou d'anticorps anti-nitrophenyles a la modification de l'interaction entre des cellules sensibles d'un hote et un agent pathogene

Publications (1)

Publication Number Publication Date
DE3853261D1 true DE3853261D1 (de) 1995-04-13

Family

ID=9356378

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853261T Expired - Lifetime DE3853261D1 (de) 1987-10-30 1988-10-28 Verwendung von Nitrophenylen oder Antinitrophenylen -Antikörpern zur Veränderung der Wechselwirkung zwischen empfindlichen Wirtszellen und einem Erreger.

Country Status (8)

Country Link
EP (1) EP0316212B1 (de)
JP (1) JPH02501932A (de)
AT (1) ATE119397T1 (de)
DE (1) DE3853261D1 (de)
DK (1) DK328289D0 (de)
FR (1) FR2622444B1 (de)
PT (1) PT88889B (de)
WO (1) WO1989003690A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015326A1 (en) * 1991-02-27 1992-09-17 The Regents Of The University Of California Targeting complex mediated immunogenicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963410D1 (en) * 1978-08-10 1982-09-16 Schering Ag Process for obtaining murine immunglobulin-e antibodies, hybrid cell lines used in the process and the process for preparing them, application of the immunglobulin-e antibodies so obtained
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4673691A (en) * 1984-11-05 1987-06-16 Nicholas Bachynsky Human weight loss inducing method

Also Published As

Publication number Publication date
WO1989003690A1 (fr) 1989-05-05
ATE119397T1 (de) 1995-03-15
DK328289A (da) 1989-06-30
EP0316212B1 (de) 1995-03-08
FR2622444B1 (fr) 1990-08-03
FR2622444A1 (fr) 1989-05-05
DK328289D0 (da) 1989-06-30
PT88889B (pt) 1993-05-31
EP0316212A1 (de) 1989-05-17
PT88889A (pt) 1989-07-31
JPH02501932A (ja) 1990-06-28

Similar Documents

Publication Publication Date Title
ATE42317T1 (de) Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
SE8304027D0 (sv) Vermikulit sasom berare for biologiska material
SE8302073D0 (sv) Immobilisering av biologiska material
SE8804073L (sv) Maetyta foer anvaendning i biosensorer
ATE15140T1 (de) Kovalent gebundene liposom-protein-verbindungen und verfahren zu deren herstellung.
ES441489A1 (es) Un metodo de ensayo radiologico de una muestra para una sus-tancia biologica.
ATE414171T1 (de) Verfahren zur immobilisierung von oligonukleotiden auf festem trägermaterial
DK160843C (da) Fremgangsmaade til fremstilling af et partikelformet, immobiliseret produkt og anvendelse af immobiliseret enzym fremstillet herved
DK1029870T3 (da) Hybride immunglobuliner til anvendelse i terapeutiske fremgangsmåder
ATE85128T1 (de) Verfahren zur unabaenderlichen bindung von proteinen auf polystyren-oberflaechen mit aufrechterhaltung ihrer biologischen wirksamkeit, derart erhaltene polystyren-oberflaechen und ihre verwendung.
DE50004951D1 (de) Verfahren zur Herstellung von stabilem Alginatmaterial
ATE111519T1 (de) Familie von modifizierten antikörpern mit hoher affinität zur behandlung von krebs.
DE3853261D1 (de) Verwendung von Nitrophenylen oder Antinitrophenylen -Antikörpern zur Veränderung der Wechselwirkung zwischen empfindlichen Wirtszellen und einem Erreger.
ATE106250T1 (de) Verwendung von antikörper-antigen-wechselwirkung zum schutz oder modulation der biologischen aktivität.
ATE70916T1 (de) Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen.
SE8600641L (sv) Nitrilofora eda-absorbenter
ATE1552T1 (de) Verfahren zur erhaltung lebender mikroorganismen.
DE3484831D1 (de) Geraet zur aussenkoerperlichen behandlung von koerperlichen fluessigkeiten.
JPS6488367A (en) Immobilized antibody
ATE26847T1 (de) Verfahren zur herstellung von perlfoermigen biokatalysatoren und ihre verwendung.
DK544085D0 (da) Fremgangsmaade til fremstilling af paa en baerer immobiliserede, hoejaktive, biologisk virksomme forbindelser
SE8703310D0 (sv) Articles exhibiting a blood-compatible surface layer and process for providing articles with such a surface layer
ATE13192T1 (de) Perlpolymerisat und dessen verwendung zur immobilisierung von enzymen.
ATE80226T1 (de) Verfahren zum nachweis von einer infektion oder entzuendung des harnbezueglichen tractus.
FI98879B (fi) Menetelmä nesteen käsittävän pakatun tuotteen sisältämien mikro-organismien kasvun säätelemiseksi ja pakkausmateriaali

Legal Events

Date Code Title Description
8332 No legal effect for de